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Abstract A Cr adhesion layer inserted between Ag nano-
particles and a glass substrate, for the purpose of improving
the adhesion of Ag nanoparticles to glass, was observed to
cause an abnormal peak shift of extinction spectra in non-
specific reactions. The undesired peak shift misleads
molecule detection in non-specific reactions. To solve this
issue, a practical technique using n-propyl-trimethoxysi-
lane-based passivation for the detection of amyloid-derived
diffusible ligands was investigated as a route to eliminate
the abnormal peak shifting observed in the non-specific
reactions. To evaluate this passivation technique, localized
surface plasmon resonance immunoassay experiments were
conducted. Experimental results derived with and without
the passivation process were investigated as a basis for
comparative analysis. Our experimental results demonstrate
that this passivation technique effectively eliminates the
observed peak shift originating from the Cr adhesion layer.
Keywords LSPR . ADDLs . Anti-ADDL . Passivation .
Cr adhesion layer
Introduction
Alzheimer’s disease (AD) is the most common cause of
dementia which gradually destroys human brain cells and
leads to a progressive decline in mental function. It is
estimated that 4.5 million Americans have AD [1–4].
People over 65 years old have a 5% to 10% incidence of
AD, which can be as high as 50% for people over 85 years
old, thus demonstrating that age is a significant factor for
the prevalence AD. Further investigation has determined
that heredity also plays an important role in the prevalence
of AD [5–9]. More females than males suffer from this
disease, primarily because females generally have greater
longevity compared to males. Moreover, 80% of live-in
caregivers for AD patients are female and are thus also
indirectly affected by AD.
The most effective and direct diagnosis of AD is through
the examination of the brain tissue of deceased AD patients.
The diagnosis of living AD patients is challenging in that
confirmation of the disease is based on an elimination of other
possible afflictions. This indirect diagnosis of AD means that
other possible dementia-causing diseases must first be
eliminated, slowing the diagnosis and the effectiveness of the
subsequent treatment. Further, it is often difficult to confirm an
AD diagnosis by a process of elimination from examination
results alone, although some of the examination data are
helpful to judge the extent of the AD for many patients.
One of the most commonly analyzed substances for AD
diagnosis is encephala. A sufficiently high protein (e.g.,
amyloid beta protein) concentration can allude to the
possibility that a patient has AD. Recently, a localized
surface plasmon resonance (LSPR)-based nano-biosensor
has been developed as a preliminary detection metric for
AD [10–15], that is, the nano-biosensor has been designed
to detect the concentration of the amyloid beta protein in
encephala. This technique can be potentially used as a tool
for the early and direct diagnosis of AD due to its ease of
operation, high sensitivity, varied application, and ability to
monitor in real time.
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Recently, researchers have found that amyloid-derived
diffusible ligands (ADDLs) cause neurological dysfunction
relevant to memory and are potential AD biomarkers. LSPR
nano-biosensors have been developed to detect ADDLs
using an anti-ADDL antibody/ADDL/anti-ADDL antibody
sandwich assay [16, 17]. Unfortunately, the Cr adhesion
layer that is used to increase the adhesion between the Ag
nanoparticles and the glass substrate causes an abnormal
peak shift in the LSPR spectra for non-specific reactions.
Ordinarily, LSPR peak shift should not be observed for
detection performed via the non-specific reaction. Fortu-
nately, the abnormal LSPR peak shift can be eliminated
using an n-propyl trimethoxysilane (PTMS)-based passiv-
ation technique that is discussed in detail in the remainder
of this paper.
Experimental
Fabrication of triangular Ag nanoparticles
The nanosphere lithography (NSL) technique was used to
fabricate discrete, triangular Ag nanoparticles [11, 14]. Of a
chemical solution with polystyrene spheres (400-nm diam-
eter), 2.2 μL was spin-coated onto a glass substrate cleaned
by a caribe solution. After natural drying, a monolayer of
nanospheres with a hexadecanethiol distribution was
formed. The monolayer of nanospheres was used as a
masking material. The sphere-covered glass sample was
fixed in a chamber with vacuum evaporation equipment. A
4-nm-thick Cr film was deposited on the nanosphere mask
to improve the adhesion of the nanoparticles fabricated in
the following steps. A 25-nm-thick Ag film was then
deposited on the sample surface. Next, the sample was
incubated in ethanol and the polystyrene spheres were
removed by ultrasonic vibration for 3 to 5 min. The pure
Ag nanoparticles and the Cr adhesion layer were left on the
glass substrate, as shown in Fig. 1. The scanning electron
microscopy (SEM) image shows that the individual nano-
particles have a triangle shape with a horizontal length of
90 nm. The average height of the nanoparticles was mea-
sured to be 35 nm using a two-dimensional stylus profiler.
Experimental setup
11-Mercaptoundecanoic acid (11-MUA), 1-octanethiol (1-
OT), and 1-ethyl-3-[3-dimethylaminopropyl] carbodiimide
hydrochloride (EDC) were acquired from Sigma-Aldrich
Corp. Biotin and streptavidin were purchased from Pierce.
Absolute ethanol and 10 mM phosphate-buffered saline
(PBS), pH=7.4, were purchased from Jinshan Company.
Ag wire (99.99%, 1-mm diameter) was obtained from Jubo
Company. The glass substrate was cleaned in a piranha
solution (1:3, 30% H2O2/H2SO4) at 80 °C for 30 min, and
then cooled by high-pressure N2. Once cooled, the glass
substrates were rinsed with copious amounts of second
distilled water and then sonicated 60 min in 5:1:1 H2O/
NH4OH/30% H2O2. Then the glass was rinsed repeatedly
with water and stored in water until used.
The extended NSL is employed here to create the
surface-confined rhombic Ag nanoparticles supported on a
glass substrate. This method is developed on the basis of
the NSL [12]. For these experiments, the single layer of
size-monodisperse polystyrene nanospheres and glass nano-
spheres solution ~10 μl were spin-coated onto the glass
substrate to form a deposition mask, followed by a process
of etching off the nanospheres from the glass using
hydrofluoric acid. After that, Ag thin film was deposited
on the nanosphere masks using thermal or electron beam
evaporation. After removal of polystyrene nanospheres by
sonication in absolute ethanol for 3 min, well ordered two-
dimensional rhombic nanoparticle arrays were finally
obtained on the substrate.
ADDLs detection
The Cr adhesion layer was observed to slightly broaden and
quench the amplitudes of the LSPR spectra of the nano-
particles (compared to that of the pure Ag nanoparticles, the
variation is less than 10%). The experimentally inserted
adhesion layer, designed for the nanoparticles, requires
rigorous fabrication and chemical conditioning processes,
as shown in Fig. 2. Before the reaction process, a self-
assembled monolayer (SAM) composed of 1:3 11-
Mercaptoundecanoic acid (11-MUA)/1-octanethiol (1-OT)
was first formed on the glass surface after incubating in
ethanol for 24 h. After completely cleaning the sample, the
biotin was covalently attached to the carboxylate groups
Fig. 1 SEM image of topography of the triangular Ag nanoparticles
fabricated using self-assembly method
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using EDC for 1 h. Each nanoparticle was covered by an
ADDL monolayer. Finally, a low concentration anti-
ADDLs IgG was deposited, followed by an assay after
incubating for 30 min in the bio-solution (see Fig. 2). The
bio-solution was prepared using a 10 mM P-buffered
solution (PBS), and all samples were cleaned using 10
and 20 mM PBS (Sigma).
The peak wavelengths of the Ag nanoparticle LSPR
extinction spectrum (λmax) corresponding to the SAM,
ADDLs, and anti-ADDLs were measured and recorded
respectively using UV–visible spectroscopy. Practical meas-
urements of the UV–visible extinction spectra were achieved
using a fiber-coupled spectrometer (Ocean Optics USB4000)
and a CCD detector. The experimental setup and subsequent
spectrum measurements were conducted using a convention-
al optical system with a non-polarized light beam working in
the far field. The detection area of the biosensor was approx-
imately 2×2 mm. All extinction spectra were directly
derived using software (Ocean Optics Corp.) that was pack-
aged together with the corresponding hardware. Figure 3
depicts a photograph of the detection system and the
investigated biosensors. A shift towards longer wavelengths
is referred to as a red shift and is denoted as (+), while a shift
towards shorter wavelengths is referred to as a blue shift and
is denoted as (−). Theoretically, the signature from a peak
wavelength shift is more reliable than the signal of amplitude
of transmission intensity for the characterization of both
physical and chemical variations originating from the nano-
particle surfaces. Although absolute maximum values (peak
position) of the extinction spectra is varied from one
biosample to another, the variations did not appear to impact
the relative variation in sensitivity of the LSPR-based
biosensor when detecting different biosamples. The differ-
ences in the absolute values from sample to sample are
caused by small differences in the dielectric value of the
aqueous absorption layer. This behavior is comparable to
how the variation of nanoparticle roughness does not
appreciably influence biosensor sensitivity. Hence, we can
denote the binding of the analytic substances using only the
relative shifting, Δλmax.
Results and discussion
The Ag nanoparticles were deposited using a chemical
solution of 3:1 1 mM 1-OT/1 mM 11-MUA SAM. The
stability of the chemical solution was significantly improved
before our binding experiments. An identical red shift to the
peak wavelength is produced in the measured extinction
spectra when the Ag nanoparticles are incubated in a ADDL
solution with a certain concentration. We assume via the red
shift that the presence of anti-ADDL in the ADDL inhibits
further development of AD. Therefore, the purpose of this
investigation was to use the deposited nanoparticles to
specifically detect these anti-ADDL antibodies. For a given
ADDL (4.5×N kDa, N=3–24) and anti-ADDL (150 kDa),
we postulate that the ADDL molecule can cause an up-shift
in the LSPR spectra relative to LSPR spectra of the anti-
Fig. 2 Reaction process between the ADDL and anti-ADDL. A self-
assembled monolayer (SAM) composed of 1:3 11-Mercaptoundecanoic
acid (11-MUA)/1-octanethiol (1-OT) was first formed on the glass
surface before the reaction process
Fig. 3 Completed optical fiber (Ocean Optics USB4000) coupled
spectrometric system and relevant biochips used in our experiments. a
Photograph of our instrumented LSPR-based immunoassay system. b
Photograph of the biochips and their holder. The four chips from top to
bottom correspond to the quartz substrate coated/attached with pure Ag
nanoparticles, Ag+SAM, Ag+SAM+ADDL, and Ag+SAM+ADDL+
antiADDL, respectively
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ADDL. In addition, the LSPR-induced shifting from the
molecule near the surface of the Ag nanoparticles is larger
than that of molecules farther away from the surface. This
effect will amplify the peak shifting of the LSPR spectra
derived from the ADDLs in comparison to that of the anti-
ADDLs.
The measured peak wavelength of the LSPR extinction
spectrum for the pure Ag nanoparticles without any
chemical processing was 487.98 nm, as depicted in 1 in
Fig. 4. After incubating the nanoparticles in the SAM
solution for 24 h, the wavelength shifted to 494.59 nm, as
depicted in 2 in Fig. 4. The sample was then incubated into
a solution composed of 100 mM EDC and 100 nM ADDL
for 1 h so as to ensure that the amide between amidocya-
nogen and carboxylate groups in the ADDLs were
completely synthesized. This binding reaction caused a
spectrum peak shift of +11.76 nm, resulting in a peak
wavelength of 505.76 nm, as shown in 3 in Fig. 4. The last
step was to detect the binding of the anti-ADDL using the
Ag nano-biochip. The ADDL-coated biochip was incubated
in a solution consisting of 100 nM anti-ADDL for 30 min.
The LSPR spectra obtained from the anti-ADDL-coated
biochip depicted a 10.0-nm peak shift relative to the anti-
ADDL and a peak wavelength of 515.51 nm (see 4 in
Fig. 4). These aforementioned experiments were completed
in atmosphere without a Cr adhesion layer.
To investigate the influence of the Cr adhesion layer on
the peak wavelength shift, we fabricated samples with a 4-
to 5-nm-thick Cr layer between the glass substrate and the
metal nanoparticles. Experiments investigating the non-
specific reaction were conducted on the chips with the Cr
adhesion layer. The SAM-disposed nanoparticles were
incubated in a 100 nM solution of anti-ADDL. Ordinarily,
the anti-ADDL molecule will only selectively bind to the
surface of a corresponding specific molecule. If the binding
occurs with a non-specific molecule, the theoretical
corresponding peak shift in the detected LSPR spectra
should be 0; however, the experimentally derived spectra
exhibited a peak shift, Δλmax, of 7.56 nm when the anti-
ADDLs contacted the SAM-disposed nanoparticles, as
depicted in Fig. 5. These data differ from the previously
reported results that indicated a Δλmax of 0 when the SAM-
disposed nanoparticles bound with non-specific anti-bodies,
demonstrating that a non-specific reaction occurred be-
tween the nanoparticles and the anti-ADDL molecule.
Figure 5 depicts the experimental non-specific binding
steps between the Ag nanoparticles and the 100 nM solution
of anti-ADDL. Pure Ag nanoparticles, without any chemical
disposal, exhibited a measured LSPR extinction spectrum
peak wavelength, λmax, of 487.98 nm, as depicted in 1 in
Fig. 5. After incubating the biochip in SAM for 24 h, the
measured LSPR wavelength, λmax, was observed to be
505.17 nm (see 2 in Fig. 5). Next, the biochip was incubated
in a 100 mM anti-ADDL solution for 1 h, resulting in a peak
shift, Δλmax, due to the binding reaction of +7.56 nm and a
corresponding LSPR peak wavelength, λmax, of 512.73 nm
(see 3 in Fig. 5). It is clear that the abnormal LSPR peak shift
associated with the Cr adhesion layer represents a detection
error and is potentially misleading for researchers. To
mitigate this detection error and potentially improve the
detection of selective binding of the as described biosensor,
we have investigated possible methods of compensation for
the peak shift associated with the Cr adhesion layer. The
mechanism associated with the non-specific reaction is not
completely understood. We assume the Cr has a greater
Fig. 4 Measured LSPR spectra for each step for testing 100 nM low
concentration of anti-ADDL using the Ag nano-biosensor. The numbers
1, 2, 3, and 4 indicate the curve for the chip with quartz substrate coated/
attached with pure Ag nanoparticles, Ag+SAM, Ag+SAM+ADDL, and
Ag+SAM+ADDL+ antiADDL, respectively
Fig. 5 Measured LSPR spectra for each step of the non-featured
interaction for testing 100 nM low concentration of anti-ADDL
using the Ag nano-biosensor. The numbers 1, 2, and 3 indicate the
curve for the chip with quartz substrate coated/attached with pure Ag
nanoparticles, Ag+SAM, and Ag+SAM+ antiADDL (with EDC),
respectively
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affinity than that of the SH groups in the alkanethiols in the
binding reaction compared to the reaction in carboxyl. Jung
and Czanderna [18] reported that the energetically binding of
Cr is superior to carboxyl groups. Residual usable thiol binds
with cysteine in the anti-ADDL molecule and forms
bisulfide. This binding increases the opportunity of the
non-specific reaction for the Cr-involved metal nanoparticles.
Previous reports have indicated that some hot spots helpful
for improving signal intensity exist at the corners and bottom
of the triangular Ag nanoparticles, which have been
attributed to a high electromagnetic field exiting the Cr
mixed region. Accordingly, the non-specific reaction is
amplified by the Cr layer.
In order to quench the Cr-induced non-specific reaction,
we passivated the Cr layer with PTMS prior to SAM
disposal. The PTMS in silane groups aggressively binds
with Cr, but not to Ag. Furthermore, methyl passivates the
dirt sites in the subsurface of the Cr layer. In our
experiments, the biochip was incubated in a 1 mM PTMS
solution immediately following the removal of the nano-
spheres and then in a SAM solution composed of 3:1 1-OT/
11-MUA for 24 h. The non-specific reaction was observed
by incubating the SAM-disposed nanoparticles in a 100 nM
anti-ADDL (without EDC) solution. The experimental
results are summarized in Fig. 6a, b. As a point of
comparison, the experimental results with and without
passivation are presented in Fig. 6a, b, respectively. The
pure Ag nanoparticles without PTMS passivation have a
typical LSPR extinction spectrum peak wavelength of
610.9 nm (see 1 in Fig. 6a). After incubating the biochip
in a SAM solution for 24 h, the observed LSPR wavelength
is 654.74 nm (see 2 in Fig. 6a). After incubating the biochip
in a 100 mM anti-ADDL (without EDC) solution for 1 h,
the subsequent LSPR wavelength was observed to shift
(Δλmax) +13.12 nm to 667.86 nm (see 3 in Fig. 6a). In
contrast, the observed peak shift and LSPR peak wave-
length for the PTMS-passivated biochip are depicted in
Fig. 6b. The biochip was incubated in a 100 mM anti-
ADDL (without EDC) solution for 1 h after the SAM
disposal. The subsequent LSPR peak shift, Δλmax, was
observed to be 0. This passivation technique clearly
eliminates the abnormal peak shift associated with the
non-specific reaction of the anti-ADDL molecules with the
SAM-disposed surface particles. Unfortunately, the PTMS
passivation process of the Cr adhesion layer also oxidizes
the Ag nanoparticles. It means that the dielectric constant of
the Ag will be changed due to the oxidation and thus affect
the peak shift of the measured LSPR spectra. To address
this new issue, the discussed method of silane passivation
needs to be further optimized. Additionally, more investi-
gation is necessary to optimally eliminate the abnormal
Fig. 6 Experimental results of without (a) and with PTMS (b)
passivation. The numbers 1, 2, and 3 indicate the curve for the chip
with quartz substrate coated/attached with pure Ag nanoparticles,
Ag+SAM, and Ag+SAM+ antiADDL (without EDC), respectively
Fig. 7 SEM image of topography of the nanoparticle array after all
the spectral measurement were completed. It shows that the metallic
nanoparticles still keep well adhesion with the substrate. There is no
peeling off phenomenon found
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peak shift associated with the non-specific reaction while
also maintaining an appropriate Ag–Cr glass device
structure. SEM image of topography after analysis of all
the spectra for Figs. 4, 5, and 6 has been collected, as
shown in Fig. 7.
The reproducibility and stability of the sensor system
mainly depend on the fabrication error of the SNL process
in which stability and uniformity of the chemical solutions
play a dominant role on the fabrication quality of the Ag
particles array. Specificity, especially the detection sensi-
tivity, is possible to be further improved if the non-specific
reaction can be completely eliminated or refrained.
Summary
In summary, an abnormal peak shift in the LSPR spectra
was observed for the non-specific reaction for a biosensor
composed of a glass substrate, a Cr adhesion layer, and an
Ag nanoparticle active layer. This abnormal shift limits the
detectivity of the biosensor and is a potential source of error
for accurate sensing. To address this issue, the Cr adhesion
layer was passivated with PMTS in order to quench peak
shifts associated with the non-specific reaction, and the
obtained data indicate that this process does result in a non-
specific reaction peak shift of zero, but at the expense of Ag
nanoparticle oxidation.
In the future, we hope that this passivation method can be
used to fabricate more effective and accurate biosensors for
the early detection of AD. By eliminating the abnormal shift
associated with the non-specific reaction, we are able to
completely assay anti-ADDLs, which can be used to better
understand the development mechanism of AD as well as
accurately diagnose the disease. These methods facilitate an
early measurement of ADDLs in possible AD patients,
potentially permitting earlier, more effective treatment. With
further improvements in the selectivity and sensitivity of the
detection methods, the LSPR biosensor can become a more
accurate and economic option for the detection of AD
compared to more conventional clinical assays.
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